Neurogene is a company focused on developing genetic medicines for people with neurological diseases. They work with experts globally to create a pipeline of programs to treat the underlying cause of serious neurological disorders. Their goal is to provide medicines to improve the lives of neurologically-impaired and developmentally-delayed children and their families. They are building a team of passionate individuals who envision a world where all families have access to genetic medicines, even for rare disorders.